申请人:——
公开号:US20020032211A1
公开(公告)日:2002-03-14
Dihydronaphthalene compounds have excellent 17&agr;-hydroxylase/C
17-20
-lyase inhibiting activity, thromboxan A
2
synthesis inhibiting activity, and aromatase inhibiting activity and are thereby are useful as preventive and/or therapeutic agents for various male sex hormone- and female sex hormone-dependent diseases such as prostate cancer, prostatomegaly, masculinization, breast cancer, mastopathy, uterine cancer, endometriosis, and ovarian cancer, as well as myocardial infarction, angina pectoris, and bronchial asthma.
二氢萘化合物具有优秀的17α-羟化酶/C17-20-裂解酶抑制活性,血栓素A2合成抑制活性和芳香化酶抑制活性,因此可用作预防和/或治疗各种男性激素和女性激素依赖性疾病的药物,如前列腺癌、前列腺增生、阳痿、乳腺癌、乳腺增生、子宫癌、子宫内膜异位症和卵巢癌,以及心肌梗死、心绞痛和支气管哮喘。